Clinical Trial Update: A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome [NA]

View source ↗

Summary

This update reports on a completed case-control study evaluating the effects of resveratrol in patients with metabolic syndrome and coronary artery disease. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Metabolic Syndrome

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Metabolic Syndrome, Coronary Artery Disease | NA | Status: COMPLETED